Austrian Airspace Off-Limits to US Military Planes

© EPA/VALDA KALNINA Vice Chancellor Andy Babler said his country desired “no involvement with Trump's policy of disarray and conflict.” Austria will not be a

© EPA/VALDA KALNINA Vice Chancellor Andy Babler said his country desired “no involvement with Trump's policy of disarray and conflict.” Austria will not be a

© EPA/AARON SCHWARTZ / POOL Further adjustments might ensue after the departures of the US Attorney General and the Secretary of Homeland Security. US President Donald

Despite all the threats and anger of President Donald Trump With allies refusing to help in the U.S. military campaign, his rhetoric has yet to be matched by any signs

The U.S. chipmaker Intel revealed a $14.2 billion transaction to acquire the ownership share of the investment firm Apollo Global Management within a joint venture that

Simultaneously, the government in Beijing endeavors to separate itself from immediate involvement in the confrontation with Iran. Flag of China / © Associated Press Following the commencement of hostilities in Iran, the quantity of trending posts on Western and Chinese…

Президент України Володимир Зеленський здійснив несподіваний візит до Дамаска. Zelensky in Syria / © Sana Президент Володимир Зеленський сьогодні, 5 квітня, перебуває з візитом у Сирії. Про це глава держави сповістив у соціальних мережах. За словами президента, головний акцент поїздки…

© Getty Images The Hungarian leader addressed his Polish counterpart. The Prime Minister of Hungary, Viktor Orban, stated that Europe is encountering “one of the most

© EPA/ CRISTOBAL HERRERA-ULASHKEVICH The War Secretary compelled General Randy George to pen a letter of resignation. US Defense Secretary Pete Hegseth has reportedly

Oil prices rose nearly 7% after President Donald Trump said the United States would continue its attacks on Iran without giving a specific timeframe for ending the war,

Zepbound, from Eli Lilly & Co., is aiding in the fight against obesity, a significant challenge to public health. Now, the pharma giant is tackling another pressing